SARS-CoV-2 (COVID-19) Array
Updated April 7, 2020
In light of the outbreak of the novel 2019 Coronavirus, Madison Core Laboratories (MCL) has stepped up to assist in filling our community’s and Long-Term Care clients’ needs by offering Molecular Diagnostic Testing for SARS-CoV-2, the cause of the respiratory disease COVID-19.
Madison Core Labs is strictly following the guidelines set forth by the Center for Disease Control (CDC). Due to the CDC strongly encouraging providers to test for other possible causes of respiratory illness and infections, we are offering a very diverse and effective Respiratory Pathogen Panel to diagnose other causes of illness. The SARS-CoV-2 (COVID-19) test will be run in combination with our Respiratory Pathogen Panel called the SARS-CoV-2 (COVID-19) Array Panel.
In late 2019, an emergence of a novel respiratory disease occurred in Wuhan, China. It was shortly thereafter discovered to be the Coronavirus Disease (COVID-19) caused by SARS-CoV-2. Since then, it has spread rapidly around the world and has been declared by the World Health Organization (WHO) as a pandemic on March 11, 2020. The WHO defines a pandemic as a global spread of a new disease. MCL has invested in the development of diagnostic testing to aid our community and the rest of the world in the fight against COVID-19.
Symptoms Related to COVID-19
The CDC reports that symptoms may appear 2-14 days after exposure with various degrees of presentation. Reported illnesses have ranged from mild to severe disease and death for confirmed COVID-19 cases. Symptoms include:
- Shortness of Breath
SARS-CoV-2 (COVID-19) Array Panel – Nasopharyngeal & Oral Swabs
Our COVID-19 assay uses real-time polymerase chain reaction (RT-PCR) technology to detect the presence of SARS-CoV-2 in respiratory samples using a nasopharyngeal (NP) or oral swab.
Clinicians are strongly encouraged by the CDC to test for other causes of respiratory illness and infections. Madison Core Laboratories offers a very diverse and effective Respiratory Pathogen Panel to diagnose for other causes of illness. The SARS-CoV-2 (COVID-19) test will be run in combination with the Respiratory Pathogen Panel. Due to the nationwide shortage of Viral Transport Media and swabs, this combination of panels also gives physicians as much information as possible while being minimally invasive to patients. The SARS-CoV-2 (COVID-19) Array Panel consists of following pathogens:
|– Haemophilus influenzae||– Respiratory Syncytial Virus Species (RSV)|
|– Klebsiella pneumoniae||– Influenza A|
|– Legionella pneumophila||– Influenza B|
|– Moraxella catarrhalis||– SARS-CoV-2 (COVID-19)|
|– Mycoplasma pneumoniae|
|– Pseudomonas aeruginosa|
|– Staphylococcus aureus|
|– Streptococcus agalactiae|
|– Streptococcus dysgalactiae|
|– Streptococcus pneumoniae|
|– Streptococcus pyogenes|
|– Bordetella pertussis|
MCL will be processing samples delivered to our lab from healthcare facilities and physician offices only. Current customers can order by the following methods:
- Send supply order form to:
- Contact your account representative
- Fax a supply order form to:
- (256) 850-3186
Call our main number (256) 850-0075 option 19 for the most up to date information on COVID-19 testing and to be transferred to a sales representative to fill out a New Facility form.
Provider Offices or Hospitals:
(256) 850-0075 option 19 then option 2
(256) 850-0075 option 19 then option 3
Call our main number (256) 850-0075 option 19 then option 1 for information and instructions on COVID-19 testing at MCL.
Center for Disease Control (CDC)
US Dept of Homeland Security (DHS)
US Food & Drug Administration (FDA)
World Health Organization (WHO)
Alabama Department of Public Health (ADPH)
ADPH Dashboard and Test Sites
Alabama COVID-19 Case Tracker